The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology

This publication has 28 references indexed in Scilit:

• From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model
  Acta Psychiatrica Scandinavica, 1985
• Tryptamine, a Substrate for the Serotonin Transporter in Human Platelets, Modifies the Dissociation Kinetics of [³H]Imipramine Binding: Possible Allosteric Interaction
  Journal of Neurochemistry, 1985
• Human platelets possess multiple [3H]imipramine binding sites
  European Journal of Pharmacology, 1984
• Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
• Substituted tetrahydro-β-carbolines are possible candidates as endogenous ligand of the [3H]Imipramine recognition site
  European Journal of Pharmacology, 1984
• Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin
  European Journal of Pharmacology, 1983
• Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist
  Inflammation Research, 1982
• Demonstration of specific “high affinity” binding sites for [3H] imipramine on human platelets
  Life Sciences, 1980
• SHAPE CHANGE OF BLOOD PLATELETS—A MODEL FOR CEREBRAL 5‐HYDROXYTRYPTAMINE RECEPTORS?
  British Journal of Pharmacology, 1979
• STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
  The Journal of cell biology, 1972